Bal Pharma Limited (BALPHARMA)
₹111.83
INR-0.47(-0.42%)
As of February 5, 2025 9:28:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹178.70 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹314.78 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
21.83
Forward P/E
Price to Earnings ratio based on forecasted earnings
NA
PEG Ratio
Price/Earnings to Growth ratio
0.11
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
0.52
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
48.45%
Operating Margin
Operating income as a percentage of revenue
5.43%
Return on Equity
Net income as a percentage of shareholders' equity
10.67%
Revenue (TTM)
Total revenue over trailing 12 months
₹343.19 Cr+5.6000000000000005%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹32.27 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹5.08+207.39999999999998%
Balance Sheet
Total Cash
Total cash and short-term investments
₹20.05 Cr
Total Debt
Total short-term and long-term debt
₹139.65 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
201.63%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹88.95 - ₹157.98
Beta
Measure of stock's volatility compared to the market
0.55
Shares Outstanding
Total number of shares issued by the company
₹1.59 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
1.00%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
NA
Payout Ratio
Percentage of earnings paid as dividends
19.84%